ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för paroxetine. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

78 träffar

Bibliografisk träff 2002-06-01

A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.

Vieta E, Martinez-Arán A, Goikolea JM, Torrent C, Colom F, Benabarre A, Reinares M.

J Clin Psychiatry · comparative study; clinical trial; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.4088/jcp.v63n0607

Bibliografisk träff 2002-04-01

Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers.

Begré S, von Bardeleben U, Ladewig D, Jaquet-Rochat S, Cosendai-Savary L, Golay KP, Kosel M, Baumann P, Eap CB.

J Clin Psychopharmacol · research support, non-u.s. gov't; journal article · DOI 10.1097/00004714-200204000-00017

Bibliografisk träff 2002-01-01

Paroxetine: an update of its use in psychiatric disorders in adults.

Wagstaff AJ, Cheer SM, Matheson AJ, Ormrod D, Goa KL.

Drugs · review; journal article · DOI 10.2165/00003495-200262040-00010

Bibliografisk träff 2002-01-01

Spotlight on paroxetine in psychiatric disorders in adults.

Wagstaff AJ, Cheer SM, Matheson AJ, Ormrod D, Goa KL.

CNS Drugs · review; journal article · DOI 10.2165/00023210-200216060-00006

Bibliografisk träff 2001-12-14

Effect of paroxetine on extracellular serotonin and dopamine levels in the prefrontal cortex.

Nakayama K.

Naunyn Schmiedebergs Arch Pharmacol · journal article · DOI 10.1007/s00210-001-0497-7

Bibliografisk träff 2001-09-01

A randomized, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment.

Baldwin DS, Hawley CJ, Mellors K, CN104-070 Study Group.

J Psychopharmacol · comparative study; clinical trial; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1177/026988110101500303

Bibliografisk träff 2001-08-01

Severe hepatotoxicity with jaundice associated with paroxetine.

Odeh M, Misselevech I, Boss JH, Oliven A.

Am J Gastroenterol · journal article; case reports · DOI 10.1111/j.1572-0241.2001.04060.x

Bibliografisk träff 2001-06-01

Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine.

Spina E, Avenoso A, Facciolà G, Scordo MG, Ancione M, Madia A.

Ther Drug Monit · research support, non-u.s. gov't; journal article · DOI 10.1097/00007691-200106000-00007

Bibliografisk träff 2001-03-01

[A patient with nodal tachycardia after general anesthesia during medication with a selective serotonin reuptake inhibitor].

Kopp R, Kunitz O, Baumert JH, Rossaint R.

Anasthesiol Intensivmed Notfallmed Schmerzther · journal article; english abstract; case reports · DOI 10.1055/s-2001-11822

Bibliografisk träff 2001-02-01

The toxicity profile of a single dose of paroxetine: an alternative approach to acute toxicity testing in the rat.

Ryan PM, Kelly JP, Chambers PL, Leonard BE.

Pharmacol Toxicol · journal article · DOI 10.1034/j.1600-0773.2001.d01-84.x

Bibliografisk träff 2001-01-01

8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze.

Kõks S, Beljajev S, Koovit I, Abramov U, Bourin M, Vasar E.

Psychopharmacology (Berl) · research support, non-u.s. gov't; journal article · DOI 10.1007/s002130000594

Bibliografisk träff 2000-09-01

Tolerability of paroxetine in Parkinson's disease: a prospective study.

Tesei S, Antonini A, Canesi M, Zecchinelli A, Mariani CB, Pezzoli G.

Mov Disord · clinical trial; journal article · DOI 10.1002/1531-8257(200009)15:5<986::aid-mds1034>3.0.co;2-i

Bibliografisk träff 1999-07-01

PET Studies of the Effect of the Antidepressant Drugs Nefazodone or Paroxetine on [11C]Raclopride Binding in Human Brain.

Fowler JS, Wang GJ, Volkow ND, Ieni J, Logan J, Pappas N, Dewey SL.

Clin Positron Imaging · journal article · DOI 10.1016/s1095-0397(99)00028-x

Bibliografisk träff 1999-04-01

Paroxetine: a review of its pharmacology, pharmacokinetics and utility in the treatment of a variety of psychiatric disorders.

Heydorn WE.

Expert Opin Investig Drugs · journal article · DOI 10.1517/13543784.8.4.417

Bibliografisk träff 1999-03-01

Role of CCK in anti-exploratory action of paroxetine, 5-HT reuptake inhibitor.

Kõks S, Bourin M, Võikar V, Soosaar A, Vasar E.

Int J Neuropsychopharmacol · journal article · DOI 10.1017/s1461145799001297

Bibliografisk träff 1999-02-01

Lack of pharmacokinetic and pharmacodynamic interaction between rizatriptan and paroxetine.

Goldberg MR, Lowry RC, Musson DG, Birk KL, Fisher A, De Puy ME, Shadle CR.

J Clin Pharmacol · clinical trial; randomized controlled trial; journal article · DOI 10.1177/00912709922007633

Bibliografisk träff 1999-01-01

Selective serotonin reuptake inhibitors for migraine prophylaxis.

Landy S, McGinnis J, Curlin D, Laizure SC.

Headache · comparative study; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1046/j.1526-4610.1999.3901028.x

Bibliografisk träff 1997-01-01

Tolerance and side-effects of paroxetine in elderly depressed patients.

Ghose K.

Arch Gerontol Geriatr · clinical trial; randomized controlled trial; journal article · DOI 10.1016/s0167-4943(96)00725-x